Skip to content

Do broadly neutralising antibodies really have a future in treating HIV?

thekopmylife/Shutterstock.com

Re-audit of hepatitis care in European HIV services finds improvement in most areas despite challenges

Dr Ann Sullivan at the EACS Standard of Care meeting. Photo by Bernard de Keyzer.

PrEP chaos: how central Europe is suffering from inconsistent guidelines, random access, and healthcare stigma

Dr Bartosz Szetela presenting at the EACS Standard of Care meeting. Photo by Bernard de Keyzer.

South Africa to begin piloting injectable PrEP in early 2023

Hryshchyshen Serhii/Shutterstock.com

Large proportion of gay and bisexual migrants with HIV acquire the virus after arrival in France

Focus and Blur/Shutterstock.com

Who is at risk of injectable treatment failure?

Professor Chloe Orkin presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

‘Real world’ injectable treatment halves patient dissatisfaction, with only two viral failures in first six months

Dr Celia Jonsson-Oldenbüttel presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.

Increasing number of pregnancies in women who grew up with HIV

Ground Picture/Shutterstock.com

Survival prospects for older people with HIV plotted accurately by simple scoring system

Dr Maxime Hentzien presenting at HIV Glasgow 2022. Image by Alan Donaldson Photography.